SCHEMBL7387448

SCHEMBL7387448

CCC(=O)Oc1c(N)cccc1C#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
TSHR P16473 2/20 0.38
NLRP3 Q96P20 1/20 0.37
ALDH1A1 P00352 4/20 0.37
GAA P10253 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CHEK1 O14757 1/20 0.36
ESR1 P03372 2/20 0.36
HIF1A Q16665 2/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
ELANE P08246 1/20 0.36
NAMPT P43490 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5285423 0.84 ACHE (0.49) ACHEALDH1A1L3MBTL1CHEK1ESR1
SCHEMBL434794 0.83 TSHR (0.38) ACHETSHRNLRP3ALDH1A1GAA
SCHEMBL25322639 0.82 NAMPT (0.37) TSHRNLRP3ALDH1A1GAAL3MBTL1
SCHEMBL28068642 0.82 KMT2A (0.39) ACHETSHRNLRP3ALDH1A1GAA
SCHEMBL7368105 0.80 SMN1; SMN2 (0.43) ACHETSHRNLRP3ALDH1A1GAA
Hydrochloric Acid SCHEMBL7365005 0.79 SMN1; SMN2 (0.42) ACHETSHRNLRP3ALDH1A1GAA
SCHEMBL7390463 0.78 ACHE (0.44) ACHENLRP3ALDH1A1CHEK1ESR1
SCHEMBL2671806 0.78 ACHE (0.47) ACHETSHRALDH1A1GAACHEK1
SCHEMBL7390544 0.78 SMN1; SMN2 (0.50) ACHETSHRALDH1A1L3MBTL1CHEK1
SCHEMBL7390728 0.76 ACHE (0.43) ACHETSHRNLRP3ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261611-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-12-04 EP disclosed
EP-1252178-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-10-30 EP disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed